Novo Holdings’ assets fell by a third in 2025 as Novo Nordisk’s value sanknews2026-03-12T07:00:56+00:00March 12th, 2026|Endpoints News|
Evotec plans up to 800 job cuts, four site closuresnews2026-03-11T19:44:46+00:00March 11th, 2026|Endpoints News|
FDA merges adverse event trackers into one databasenews2026-03-11T19:44:22+00:00March 11th, 2026|Endpoints News|
Eli Lilly CEO David Ricks seeks ‘exit velocity’ for pharma’s futurenews2026-03-11T14:37:56+00:00March 11th, 2026|Endpoints News|
Lundbeck CEO talks drug pricing, protecting biotech and European needsnews2026-03-10T18:28:19+00:00March 10th, 2026|Endpoints News|
FDA widens use of leucovorin without new trial datanews2026-03-10T13:00:12+00:00March 10th, 2026|Endpoints News|
Ipsen pulls cancer drug Tazverik from market over safety risksnews2026-03-09T18:16:40+00:00March 9th, 2026|Endpoints News|
Hims agrees to limit compounding, ending feud with Novo Nordisknews2026-03-09T14:44:20+00:00March 9th, 2026|Endpoints News|
Incyte receives CRL over issues at Novo’s Indiana factorynews2026-03-09T13:21:57+00:00March 9th, 2026|Endpoints News|
Lonza sells capsule and health ingredients unit for $2.2Bnews2026-03-06T19:50:51+00:00March 6th, 2026|Endpoints News|
